Logo
  • Empower your research with Pharmidex, a leading CRO offering advanced solutions in Bioanalysis (GLP/GCP), CNS, DMPK, Oncology, Immunology, Respiratory, and Toxicology (GLP).

    Slide title

    Empower your research with Pharmidex, a leading CRO offering advanced solutions in Bioanalysis (GLP/GCP), CNS, DMPK, Oncology, Immunology, Respiratory, and Toxicology (GLP).

    Button
  • Unlock the full potential of your research with Pharmidex, your trusted partner in drug discovery, offering unparalleled expertise and innovative solutions to drive your projects toward success.

    Slide title

    Unlock the full potential of your research with Pharmidex, your trusted partner in drug discovery, offering unparalleled expertise and innovative solutions to drive your projects toward success.

    Button

Service Offerings

Therapeutic Areas

Services By Developmental Phase

Latest News

Who We Are

About us

Pharmidex is a contract research organisation (CRO) that provides translational solutions using its world-renowned expertise in CNS, oncology, respiratory, DMPK, drug discovery and ADMET/pharmacokinetics.


Founded in the UK, in 2002, Pharmidex operates in state-of-the-art facilities in Hertfordshire to provide high-quality experimental data and expert guidance to support drug discovery and development.

Home

Key Facts

Experts in therapeutic preclinical models 


Accredited by AAALAC and the MHRA to perform GLP and GCP certified services

Home

Services

Single site service offering with 15,000+ studies conducted to date


Quick turnaround times, cost effective research, expert interpretation and customer-focused approach

Home

Our History

Successfully helped multiple clients reach clinical development since 2002

News

DMPK Services News! More News!
February 26, 2025
Pharmidex continues advancing computational drug discovery! After identifying active/binding sites, our Molecular Docking step ensures precise interaction analysis between potential drug candidates and target proteins, streamlining lead optimization. ✨ Why is this step key? ✅ Predicts binding affinity and stability of drug candidates ✅ AI-enhanced docking for high-precision molecular interactions ✅ Accelerates hit-to-lead identification with accurate simulations ✅ Seamlessly integrates with the next in silico pipeline steps By combining cutting-edge modeling and expert-driven analysis, we de-risk drug development and fast-track novel therapeutic discoveries. 📽️ Watch our latest video (3/5) showcasing how we refine drug-target interactions through Molecular Docking! 📩 Let’s collaborate to transform drug discovery! #DrugDiscovery #Pharmidex #AIinBiotech #MolecularDocking #PharmaceuticalInnovation
OBN BioTuesday
February 25, 2025
OBN BioTuesday
February 25, 2025
At Pharmidex , we continue to push the boundaries of computational drug discovery! Following target structure and ligand determination, our advanced Determination of Active/Binding Sites step ensures precise identification of key molecular interactions, optimizing drug design for success. ✨ Why is this step crucial? ✅ Accurate identification of binding pockets for targeted drug interactions ✅ AI-powered pocket detection and molecular dynamics simulations ✅ Enhanced precision in hit identification and lead optimization ✅ Seamless integration with our next in silico pipeline steps By leveraging cutting-edge computational tools, we de-risk drug development and accelerate therapeutic innovation. Stay tuned for the next stage in our in silico pipeline! 📽️ Watch our latest video (2/5) to explore how we map active sites with precision! 📩 Let’s collaborate to revolutionize drug discovery! #DrugDiscovery #Pharmidex #AIinBiotech #MolecularModeling #PharmaceuticalInnovation
Services by Department
Share by: